Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | PTGFR | P43088 | 3/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | F2R | P25116 | 1/20 | 0.30 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21708770 | 0.92 | PTGFR (0.35) | PTGFR | |
| SCHEMBL21708491 | 0.90 | PTGFR (0.37) | PTGFRF2R | |
| SCHEMBL21708580 | 0.90 | KMT2A (0.34) | — | |
| SCHEMBL21708507 | 0.87 | PTGFR (0.33) | PTGFR | |
| SCHEMBL21708658 | 0.86 | TAS1R3 (0.34) | TAS1R3TAS1R1PTGFRCES2CES1 | |
| SCHEMBL21708612 | 0.86 | TAS1R3 (0.32) | TAS1R3TAS1R1F2R | |
| SCHEMBL21708727 | 0.85 | PTGFR (0.30) | PTGFR | |
| SCHEMBL21708464 | 0.85 | PTGFR (0.35) | TAS1R3TAS1R1PTGFR | |
| SCHEMBL21708615 | 0.82 | PTGFR (0.35) | PTGFR | |
| SCHEMBL21708602 | 0.81 | SMN1; SMN2 (0.33) | PTGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3609869-A1 | SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | Bayer Aktiengesellschaft (DE) | 2020-02-19 | — | — | EP | disclosed |
| EP-3609870-A1 | SUBSTITUTED N-ARYLETHYL-2-AMINOQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | Bayer Aktiengesellschaft (DE) | 2020-02-19 | — | — | EP | disclosed |